Key result
Boxers with arrhythmogenic right ventricular cardiomyopathy and congestive heart failure had significantly reduced heart rate variability compared to normal dogs and Boxers without heart failure.
Why the study?
Does heart rate variability differ among Boxers with varying severities of arrhythmogenic right ventricular cardiomyopathy compared to normal dogs?
Observational (n=34)
No
Does heart rate variability differ among Boxers with varying severities of arrhythmogenic right ventricular cardiomyopathy compared to normal dogs?
Absolute Event Rate: 152% vs 412%
p-value: p=<0.05
Heart rate variability is reduced in Boxers with ARVC and congestive heart failure, but does not differentiate between Boxers with and without severe ventricular arrhythmias in the absence of heart failure.
Associates reduced HRV with CHF in ARVC Boxers; leaves open utility for arrhythmia risk stratification without failure.
OBJECTIVE: To assess heart rate variability (HRV) in Boxers with arrhythmogenic right ventricular cardiomyopathy (ARVC), assess the ability of HRV analysis to identify differences in Boxers on the basis of severity of their arrhythmia, and evaluate the use of HRV to determine whether persistently high sympathetic tone is present in these dogs. DESIGN: Prospective study. ANIMALS: 24 Boxers with ARVC and 10 clinically normal non-Boxer dogs. PROCEDURE: Boxers were categorized as dogs with congestive heart failure (CHF), dogs with < or = 2 ventricular premature complexes (VPCs)/24 h (designated unaffected), or dogs with > 1,000 VPCs/24 h (designated affected). Ambulatory electrocardiography (24 hours) was performed in each dog. Recordings were analyzed for HRV variables at a commercial laboratory; differences in HRV variables among groups were compared with 1-way ANOVA. RESULTS: Compared with control non-Boxer dogs and Boxers without CHF (affected and unaffected Boxers), HRV was reduced in Boxers with CHF. No differences in HRV variables were detected between affected and unaffected Boxers. Inconsistent differences were identified between the control dogs and Boxers without CHF that had various degrees of arrhythmias. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that persistently high sympathetic tone is not a consistent feature of ARVC. Differences in some HRV variables between Boxers without CHF and control dogs suggest that Boxers may have different autonomic control of heart rate, compared with that of clinically normal non-Boxer dogs. The usefulness of HRV analysis appears limited to Boxers with ARVC that have systolic dysfunction and CHF.
No takes yet. Share an insight, caveat, or question.
Spier et al. (2004) conducted an observational in Arrhythmogenic right ventricular cardiomyopathy (ARVC) (n=34). Arrhythmogenic right ventricular cardiomyopathy with congestive heart failure vs. Clinically normal non-Boxer dogs and Boxers without congestive heart failure was evaluated on Heart rate variability (SDNN) (p=<0.05). Boxers with arrhythmogenic right ventricular cardiomyopathy and congestive heart failure had significantly reduced heart rate variability compared to normal dogs and Boxers without heart failure.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: